Ravi Vyzasatya serves as Director, Head of Global Technical Specialists at Lonza Specialized Modalities. In his current role, he leverages over 20 years of biopharma experience in academia and industry to lead a global team of technical specialists in supporting the manufacturing of cell and gene, mRNA-based, and microbial-based therapies. During his 15-year tenure at Lonza, Ravi has focused on developing manufacturing processes and analytical methods for a wide range of cell and gene therapies. His expertise spans early-stage process development through late-stage, BLA-enabling activities across diverse therapeutic cell types. Ravi holds a degree in Molecular Biology from the University of Minnesota.